Icosagen offers custom-tailored services for antibody development and recombinant protein production. We use patented state-of-the-art technologies to deliver high quality products to biopharmaceutical and diagnostic companies.
We develop recombinant monoclonal antibodies by isolating variable regions directly from B-cells of immunized animals (or from hybridomas). This approach allows to deliver 1mg of monoclonal antibodies from chicken as fast as 12 weeks, and develop antibodies from rabbits with picomolar affinities.
For recombinant protein production, we use patented stable episomal expression system, where expression vectors are maintained at few hundred copies per mammalian cell. This enables to produce antibodies/antigens in gram-scale and generate production cell banks within 10 days after the transfection.
Icosagen is ISO 9001:2008 certified, and follows GLP guidelines. Our customers are global pharmaceutical and diagnostic companies, including Novartis, Bayer, Sanofi Pasteur.